Keyphrases
Langerhans Cell Sarcoma
100%
Cutaneous Involvement
100%
Extracutaneous
50%
Tumor Cells
33%
Tumor
33%
Organ Involvement
33%
Cytokeratin
16%
Immunohistochemistry
16%
Knee
16%
S100 Proteins
16%
Histological Analysis
16%
Cytological Atypia
16%
Melanoma Cells
16%
Middle-aged
16%
Regular Follow-up
16%
Male Patients
16%
CHOP Regimen
16%
CD20
16%
Subcutaneous Tissue
16%
Poor Prognosis
16%
CD21
16%
Regional Lymph Nodes
16%
Multiple Organs
16%
Aggressiveness
16%
Systemic Chemotherapy
16%
Radiographic Evaluation
16%
Dermis
16%
Primary Cutaneous
16%
HMB-45
16%
Whole-body Positron Emission Tomography/computed Tomography
16%
Cutaneous Lesions
16%
Nodular Lesion
16%
Extensor
16%
Cytological Features
16%
High-grade Malignancy
16%
CD1a
16%
Medicine and Dentistry
Langerhans Cell Sarcoma
100%
Neoplasm
33%
Tumor Cell
33%
Diseases
16%
CD3 Antigen
16%
Cytokeratin
16%
S-100 Protein
16%
Cancer
16%
Immunohistochemistry
16%
Lymph Node
16%
CD20
16%
CHOP
16%
Middle Age
16%
Radiodiagnosis
16%
Dermis
16%
Skin Defect
16%
Subcutaneous Tissue
16%
HMB-45
16%
Melan A
16%
Physical Examination
16%
Positron Emission Tomography-Computed Tomography
16%
Langerhans Cell
16%
Computed Tomography Studies
16%
Whole Body PET
16%